Area of research
Oncology · Biotechnology
Research interest
Research interests include Cancer Research and Treatments, Cell Adhesion Molecules Research, Lung Cancer Treatments and Mutations, and Vascular Tumors and Angiosarcomas.
The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma
TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors
Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors
Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells